Advertisement

Psoriasis Often Goes Untreated or Undertreated — Physician’s First Watch

Medical News |
August 15, 2013

Psoriasis Often Goes Untreated or Undertreated

By Kelly Young

Patients with psoriasis are frequently untreated or undertreated, and those who are treated are often dissatisfied with the results, according to a study in JAMA Dermatology.

Some 5600 patients with psoriasis or psoriatic arthritis completed surveys about their treatments between 2003 and 2011. In 2011, 24% of patients with moderate psoriasis and 9% of patients with severe psoriasis (>10% of body surface area) were not being treated. One in three patients with moderate disease and 22% with severe disease received only topical drugs. One of the main reasons was that the providers did not prescribe an alternative.

UV-B was the most commonly used phototherapeutic treatment, and methotrexate was used more often than acitretin or cyclosporine.

Dissatisfaction with treatment was high, with just over half of patients with psoriasis and 46% with psoriatic arthritis reporting they were dissatisfied. Primary reasons for discontinuation of a biologic agent were adverse events and the patient's perception that the drug was not effective.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement